top of page

In Vitro Toxicology/ Toxicity Testing Market Worth $14.4 Billion by 2025|Meticulous Research®

  • Writer: Kavita Phadatare
    Kavita Phadatare
  • Nov 5, 2019
  • 4 min read

Meticulous Research® – a leading global market research company published a research report titled “In-Vitro Toxicology/Toxicity Testing Market by Product& Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025”.



According to this latest publication from Meticulous Research®, the global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025. The growth of this market is driven by factors, such as ethical issues and pressure from animal activists’ groups concerning the use of animals for testing, ban on animal testing on cosmetic products, support from regulatory bodies regarding the approval of in-vitro tests, low costs associated with in-vitro toxicology testing, and advancements in in-vitro methodologies. Moreover, synergetic relationships between various stakeholders in the industry and increasing toxicology databases to facilitate the use of in-vitro test methods are expected to offer significant growth opportunities for the players operating in this market.


The global in-vitro toxicology testing market study presents historical market data in terms of value (2018), estimated current data (2019), and forecasts for 2025-by product & service (equipment, assay kits, consumables, software, services), technology (cell culture technologies, high-throughput screening technologies, OMICS technologies), method (cell-based assays, biochemical assays, in-silico, ex-vivo), end-point (ADME; skin irritation, corrosion, sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; and dermal toxicity), end-user (pharmaceutical & biotechnology industries, cosmetics industry, food industry, and chemical industry). The study also evaluates industry competitors and analyzes the market at a regional and country level.



key topics covered in report:

1. Introduction      1.1. Market Definition      1.2. Market Segmentation      1.3. Currency      1.4. Limitations      1.5. Key Stakeholders 

2. Research Methodology      2.1. Research Process             2.1.1. Secondary Research             2.1.2. Primary Research             2.1.3. Market Size Estimation

3. Executive Summary      3.1. Introduction      3.2. Market Dynamics      3.3. Market Assessment, by Product      3.4. Market Assessment, by Technology      3.5. Market Assessment, by Method      3.6. Market Assessment, by End Point      3.7. Market Assessment, by End User      3.8. Regional Analysis      3.9. Competitive Analysis 

4. Market Insights      4.1. Introduction      4.2. Drivers             4.2.1. Ban on Animal Testing for Cosmetics             4.2.2. Need to Develop Early Toxicology Testing Methods             4.2.3. Advancements in In Vitro Methodologies             4.2.4. Low Cost Associated with In Vitro Methodologies      4.3. Restraints             4.3.1. Failure to Establish Intricacies of In Vivo Conditions             4.3.2. Limited In Vitro Models to Test Complex Endpoints      4.4. Opportunities             4.4.1. Synergistic Relationships between Industry Stakeholders             4.4.2. Increasing Toxicology Databases      4.5. Regulatory Agencies 

5. In Vitro Toxicology Testing Market, by Product and Service      5.1. Introduction      5.2. Equipment      5.3. Assay Kits      5.4. Consumables      5.5. Software      5.6. Services 

6. In Vitro Toxicology Testing Market, by Technology      6.1. Introduction      6.2. Cell Culture Technologies      6.3. High-Throughput Screening Technologies      6.4. Omics Technologies 

7. In Vitro Toxicology Testing Market, by Method      7.1. Introduction      7.2. Cell-Based Assays      7.3. Biochemical Assays      7.4. In-Silico      7.5. Ex-Vivo 

8. In Vitro Toxicology Testing Market, by End Point      8.1. Introduction      8.2. ADME (Absorption, Distribution, Metabolism, Excretion)      8.3. Skin Irritation, Corrosion, & Sensitization      8.4. Genotoxicity      8.5. Cytotoxicity      8.6. Ocular Toxicity      8.7. Organ Toxicity      8.8. Phototoxicity      8.9. Dermal Toxicity      8.10. Other Toxicity End Points 

9. In Vitro Toxicology Testing Market, by End User      9.1. Introduction      9.2. Pharmaceutical and Biotechnology Industry      9.3. Cosmetics Industry      9.4. Food Industry      9.5. Chemical Industry 

10. Geographic Analysis         10.1. Introduction         10.2. Europe                 10.2.1. Germany                 10.2.2. U.K.                 10.2.3. France                 10.2.4. Italy                 10.2.5. Spain                 10.2.6. Rest of Europe         10.3. North America                 10.3.1. U.S.                 10.3.2. Canada          10.4. Asia Pacific                   10.4.1. China                   10.4.2. Japan                   10.4.3. India                   10.4.4. RoAPAC           10.5. Latin America           10.6. Middle East and Africa 

11. Competitive Landscape         11.1. Competitive Growth Strategies         11.2. Market Share Analysis                 11.2.1. Thermo Fisher Scientific                 11.2.2. Merck KgaA                 11.2.3. GE Healthcare 


This research report analyzes major geographies and provides comprehensive analysis of Europe (Germany, U.K., France, Italy, Spain, and RoE), North America (U.S., Canada), Asia-Pacific (China, Japan, India,and RoAPAC), Latin America, and Middle East & Africa. Europe commanded the largest share of the global in-vitro toxicology testing market, followed by North America and Asia Pacific (APAC). The large share of this region is mainly attributed to the factors such as ban on animal testing for cosmetics and its ingredients, and government initiatives to promote the reduction of use of animals for toxicity testing. Asia-Pacific region is expected to grow at the highest CAGR during the forecast period of 2019 to 2025, owing to increasing biotech investments in this region and growing collaborations between local and foreign companies.


In-vitro toxicology testing market is a highly consolidated in nature, wherein 3 major players — Thermo Fisher Scientific (US), Merck (Germany), and GE Healthcare (US) — accounted for major share of the global in-vitro toxicity testing market. Other key players operating in this market are Bio-Rad Laboratories (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (U.S.), Qiagen N.V. (Netherlands), and Eurofins Scientific (Luxembourg), among others.


Contact Us:

Meticulous Research®

Contact Sales- +1-646-781-8004

Follow:http://research3.over-blog.com/

Comments


Get in Touch

Never miss an update

  • LinkedIn Social Icon

© 2023 by Make Some Noise.

Proudly created with Wix.com

bottom of page